
Published
04 May 2011 | By Kinapse
The biosciences sector has witnessed numerous challenges during recent years, as the global economic downturn has adversely impacted sector liquidity and undermined investor confidence. But now, as the sector begins to show signs of recovery, emerging and developing companies with innovative platforms and products have unique opportunities to build sustainable growth over the long-term. This paper outlines the leaner and fitter sector that is set to emerge from the global recession, and suggests how developing companies can position themselves to exploit the changing competitive landscape of the life sciences industry and capture significant industry value.
As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Fill In Details
By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory
Fields marked * are compulsory